TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...

Below is Validea's guru fundamental report for TRANSMEDICS GROUP INC (TMDX). Of the 22 guru strategies we follow, TMDX rates highest using our P/B Growth Investor model based on the published ...

TransMedics Gr TMDX has outperformed the market over the past 5 years by 15.56% on an annualized basis producing an average ...

Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.